We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 838

FDA proposes regulatory framework for laboratory-developed tests
  • Sidley Austin LLP
  • USA
  • February 22 2017

In an unusual move, the Food and Drug Administration (FDA) recently published a Discussion Paper which proposes a new regulatory framework for


Court Rejects Armstrong’s Motion for Summary Judgment, ignoring Escobar, and Sets the Case for Trial Where Armstrong Faces Nearly $100M in Damages
  • Sidley Austin LLP
  • USA
  • February 17 2017

On February 13, 2017, the District Court for the District of Columbia rejected motions for summary judgment filed by cyclist Lance Armstrong and his


Health matters: navigating ACA reform
  • Sidley Austin LLP
  • USA
  • February 15 2017

Republican control of the White House and Congress is expected to bring sweeping healthcare changes beginning in the earliest days of 2017. The


New Republican Study Committee legislation to repeal and replace Affordable Care Act
  • Sidley Austin LLP
  • USA
  • February 15 2017

The Republican Study Committee recently released the American Healthcare Reform Act of 2017, which would repeal and replace the Affordable Care Act


Chinese Government Publishes Comprehensive, Ambitious Plan for Drug System Reform, Calling for Significant Changes
  • Sidley Austin LLP
  • China
  • February 14 2017

On February 9, the State Council of China published a policy document titled "Opinions on Further Reform and Improvement of Drug Manufacturing and


First Circuit Affirms Strict Limits of FCA Reach
  • Sidley Austin LLP
  • USA
  • February 14 2017

In U.S. ex rel. Alex Booker and Edmund Hebron v. Pfizer, Inc., the U.S. Court of Appeals for the First Circuit affirmed two district court judgments


Chinese Government Publishes Comprehensive, Ambitious Plan for Drug System Reform, Calling for Significant Changes
  • Sidley Austin LLP
  • China
  • February 13 2017

On Feb. 9, the State Council of China published a policy document titled “Opinions on Further Reform and Improvement of Drug Manufacturing and


Senate Approves Rep. Tom Price for Department of Health and Human Services Secretary on Party Lines, 52-47
  • Sidley Austin LLP
  • USA
  • February 10 2017

In the early morning of Feb. 10, the Senate approved Rep. Tom Price (R-GA) to be the Secretary of the Department of Health and Human Services (HHS


Medicare Payment Advisory Commission Focuses on Part B and Part D Reforms
  • Sidley Austin LLP
  • USA
  • February 9 2017

During its two-day meeting in January, the Medicare Payment Advisory Commission (MedPAC) discussed potential drug pricing and reimbursement reforms


House Energy and Commerce Health Subcommittee Debates Two Medicaid Reform Bills
  • Sidley Austin LLP
  • USA
  • February 9 2017

On Feb. 7, the House of Representatives Energy and Commerce Committee's Health Subcommittee held its first markup of 2017. It considered two Medicaid